1. Effects of trastuzumab and afatinib on kinase activity in gastric cancer cell lines. Issue 4 (10th March 2018) Authors: Keller, Simone; Zwingenberger, Gwen; Ebert, Karolin; Hasenauer, Jan; Wasmuth, Jacqueline; Maier, Dieter; Haffner, Ivonne; Schierle, Katrin; Weirich, Gregor; Luber, Birgit Journal: Molecular oncology Issue: Volume 12:Issue 4(2018) Page Start: 441 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. HER2 Expression, Test Deviations, and Their Impact on Survival in Metastatic Gastric Cancer: Results From the Prospective Multicenter VARIANZ Study. Issue 13 (1st May 2021) Authors: Haffner, Ivonne; Schierle, Katrin; Raimúndez, Elba; Geier, Birgitta; Maier, Dieter; Hasenauer, Jan; Luber, Birgit; Walch, Axel; Kolbe, Katharina; Riera Knorrenschild, Jorge; Kretzschmar, Albrecht; Rau, Beate; Fischer von Weikersthal, Ludwig; Ahlborn, Miriam; Siegler, Gabriele; Fuxius, Stefan; Dec... Journal: Journal of clinical oncology Issue: Volume 39:Issue 13(2021) Page Start: 1468 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Metabolomic therapy response prediction in pretherapeutic tissue biopsies for trastuzumab in patients with HER2‐positive advanced gastric cancer. Issue 9 (26th September 2021) Authors: Kunzke, Thomas; Hölzl, Fabian T.; Prade, Verena M.; Buck, Achim; Huber, Katharina; Feuchtinger, Annette; Ebert, Karolin; Zwingenberger, Gwen; Geffers, Robert; Hauck, Stefanie M.; Haffner, Ivonne; Luber, Birgit; Lordick, Florian; Walch, Axel Journal: Clinical and translational medicine Issue: Volume 11:Issue 9(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗